Recommendations on the Use of Anti-CGRP Monoclonal Antibodies in Children and Adolescents

Christina L. Szperka; Juliana VanderPluym; Serena L. Orr; Christopher B. Oakley; William Qubty; Irene Patniyot; Ana Marissa Lagman-Bartolome; Cynthia Morris; Jessica Gautreaux; M. Cristina Victorio; Suzanne Hagler; Sona Narula; Meghan S. Candee; Catalina Cleves-Bayon; Rashmi Rao; Robert H. Fryer; Alma R. Bicknese; Marcy Yonker; Andrew D. Hershey; Scott W. Powers; Peter J. Goadsby; Amy A. Gelfand

doi:10.1111/head.13414

Recommendations on the Use of Anti-CGRP Monoclonal Antibodies in Children and Adolescents

Christina L. Szperka, Juliana VanderPluym, Serena L. Orr, Christopher B. Oakley, William Qubty, Irene Patniyot, Ana Marissa Lagman-Bartolome, Cynthia Morris, Jessica Gautreaux, M. Cristina Victorio, Suzanne Hagler, Sona Narula, Meghan S. Candee, Catalina Cleves-Bayon, Rashmi Rao, Robert H. Fryer, Alma R. Bicknese, Marcy Yonker, Andrew D. Hershey, Scott W. PowersPeter J. Goadsby, Amy A. Gelfand

School of Medicine

Research output: Contribution to journal › Article › peer-review

18 Scopus citations

Original language	English (US)
Pages (from-to)	1658-1669
Number of pages	12
Journal	Headache
Volume	58
Issue number	10
DOIs	https://doi.org/10.1111/head.13414
State	Published - Nov 1 2018

Keywords

adolescent
calcitonin gene-related peptide
migraine
monoclonal antibody
pediatric

ASJC Scopus subject areas

Neurology
Clinical Neurology

Access to Document

10.1111/head.13414

Cite this

Szperka, C. L., VanderPluym, J., Orr, S. L., Oakley, C. B., Qubty, W., Patniyot, I., Lagman-Bartolome, A. M., Morris, C., Gautreaux, J., Victorio, M. C., Hagler, S., Narula, S., Candee, M. S., Cleves-Bayon, C., Rao, R., Fryer, R. H., Bicknese, A. R., Yonker, M., Hershey, A. D., ... Gelfand, A. A. (2018). Recommendations on the Use of Anti-CGRP Monoclonal Antibodies in Children and Adolescents. Headache, 58(10), 1658-1669. https://doi.org/10.1111/head.13414

Szperka, CL, VanderPluym, J, Orr, SL, Oakley, CB, Qubty, W, Patniyot, I, Lagman-Bartolome, AM, Morris, C, Gautreaux, J, Victorio, MC, Hagler, S, Narula, S, Candee, MS, Cleves-Bayon, C, Rao, R, Fryer, RH, Bicknese, AR, Yonker, M, Hershey, AD, Powers, SW, Goadsby, PJ & Gelfand, AA 2018, 'Recommendations on the Use of Anti-CGRP Monoclonal Antibodies in Children and Adolescents', Headache, vol. 58, no. 10, pp. 1658-1669. https://doi.org/10.1111/head.13414

@article{904efa9ed381484c8d97a3918e2159a8,

title = "Recommendations on the Use of Anti-CGRP Monoclonal Antibodies in Children and Adolescents",

keywords = "adolescent, calcitonin gene-related peptide, migraine, monoclonal antibody, pediatric",

author = "Szperka, {Christina L.} and Juliana VanderPluym and Orr, {Serena L.} and Oakley, {Christopher B.} and William Qubty and Irene Patniyot and Lagman-Bartolome, {Ana Marissa} and Cynthia Morris and Jessica Gautreaux and Victorio, {M. Cristina} and Suzanne Hagler and Sona Narula and Candee, {Meghan S.} and Catalina Cleves-Bayon and Rashmi Rao and Fryer, {Robert H.} and Bicknese, {Alma R.} and Marcy Yonker and Hershey, {Andrew D.} and Powers, {Scott W.} and Goadsby, {Peter J.} and Gelfand, {Amy A.}",

note = "Funding Information: Conflict of Interest: Christina Szperka: Has received grant support from Pfizer and Amgen. Juliana VanderPluym: Reports speaking fees for Amgen and Novartis, and consulting for Healint. Serena L. Orr: Receives royalties from Cambridge University Press. Christopher Oakley: None. William Qubty: None. Irene Patniyot: None. Ana Marissa Lagman-Bartolome: Is on the advisory board for Teva, Novartis, and Allergan and the speakers{\textquoteright} bureau for Aralez. Cynthia Morris: None. Jessica Gautreaux: Speaker{\textquoteright}s bureau for Supernus and has received travel funds from the American Academy of Neurology. M. Cristina Victorio: Has received travel funds from the American Academy of Neurology and honoraria for authorship from Merck. Suzanne Hagler: None. Meghan S. Candee: None. Catalina Cleves-Bayon: None. Rashmi Rao: None. Robert H. Fryer: Receives funding from the National Institutes of Health. Alma R. Bicknese: None. Marcy Yonker: Has received consulting fees from Amgen, Impax, Upsher-Smith, and Avanir. Andrew D. Hershey: Alder, Amgen, Curelator, Depomed, Electrocore, Impax, Lilly, Teva, and Upsher-Smith. Scott W. Powers: Receives funding from the NIH. Peter J. Goadsby: Grants and personal fees from Amgen and Eli-Lilly and Company, and personal fees from Alder Biopharmaceuticals, Allergan, Autonomic Technologies Inc., Dr. Reddy{\textquoteright}s Laboratories, Electrocore LLC, eNeura, Novartis, Scion, Teva Pharmaceuticals, Trigemina Inc., MedicoLegal work, Journal Watch, UpToDate, Oxford University Press, Massachusetts Medical Society, and Wolters Kluwer; and a patent Magnetic stimulation for headache assigned to eNeura without fee. Amy A. Gelfand: Has received consulting fees from Zosano, Eli Lilly, Impax, and Biohaven. She has received honoraria from UpToDate (for authorship) and JAMA Neurology (as an associate editor). eNeura provides consulting payments for work done by Dr. Gelfand to the UCSF Pediatric Headache program. She receives personal compensation for medical-legal consulting. Her spouse receives consulting fees from Genentech, research support from Genentech, Quest Diagnostics, and MedDay, and personal compensation for medical-legal consulting. Funding Information: Funding: Dr. Szperka receives research funding from the National Institutes of Health (K23NS102521). There was no specific funding for this project.",

year = "2018",

month = nov,

day = "1",

doi = "10.1111/head.13414",

language = "English (US)",

volume = "58",

pages = "1658--1669",

journal = "Headache",

issn = "0017-8748",

publisher = "Wiley-Blackwell",

number = "10",

}

TY - JOUR

T1 - Recommendations on the Use of Anti-CGRP Monoclonal Antibodies in Children and Adolescents

AU - Szperka, Christina L.

AU - VanderPluym, Juliana

AU - Orr, Serena L.

AU - Oakley, Christopher B.

AU - Qubty, William

AU - Patniyot, Irene

AU - Lagman-Bartolome, Ana Marissa

AU - Morris, Cynthia

AU - Gautreaux, Jessica

AU - Victorio, M. Cristina

AU - Hagler, Suzanne

AU - Narula, Sona

AU - Candee, Meghan S.

AU - Cleves-Bayon, Catalina

AU - Rao, Rashmi

AU - Fryer, Robert H.

AU - Bicknese, Alma R.

AU - Yonker, Marcy

AU - Hershey, Andrew D.

AU - Powers, Scott W.

AU - Goadsby, Peter J.

AU - Gelfand, Amy A.

N1 - Funding Information: Conflict of Interest: Christina Szperka: Has received grant support from Pfizer and Amgen. Juliana VanderPluym: Reports speaking fees for Amgen and Novartis, and consulting for Healint. Serena L. Orr: Receives royalties from Cambridge University Press. Christopher Oakley: None. William Qubty: None. Irene Patniyot: None. Ana Marissa Lagman-Bartolome: Is on the advisory board for Teva, Novartis, and Allergan and the speakers’ bureau for Aralez. Cynthia Morris: None. Jessica Gautreaux: Speaker’s bureau for Supernus and has received travel funds from the American Academy of Neurology. M. Cristina Victorio: Has received travel funds from the American Academy of Neurology and honoraria for authorship from Merck. Suzanne Hagler: None. Meghan S. Candee: None. Catalina Cleves-Bayon: None. Rashmi Rao: None. Robert H. Fryer: Receives funding from the National Institutes of Health. Alma R. Bicknese: None. Marcy Yonker: Has received consulting fees from Amgen, Impax, Upsher-Smith, and Avanir. Andrew D. Hershey: Alder, Amgen, Curelator, Depomed, Electrocore, Impax, Lilly, Teva, and Upsher-Smith. Scott W. Powers: Receives funding from the NIH. Peter J. Goadsby: Grants and personal fees from Amgen and Eli-Lilly and Company, and personal fees from Alder Biopharmaceuticals, Allergan, Autonomic Technologies Inc., Dr. Reddy’s Laboratories, Electrocore LLC, eNeura, Novartis, Scion, Teva Pharmaceuticals, Trigemina Inc., MedicoLegal work, Journal Watch, UpToDate, Oxford University Press, Massachusetts Medical Society, and Wolters Kluwer; and a patent Magnetic stimulation for headache assigned to eNeura without fee. Amy A. Gelfand: Has received consulting fees from Zosano, Eli Lilly, Impax, and Biohaven. She has received honoraria from UpToDate (for authorship) and JAMA Neurology (as an associate editor). eNeura provides consulting payments for work done by Dr. Gelfand to the UCSF Pediatric Headache program. She receives personal compensation for medical-legal consulting. Her spouse receives consulting fees from Genentech, research support from Genentech, Quest Diagnostics, and MedDay, and personal compensation for medical-legal consulting. Funding Information: Funding: Dr. Szperka receives research funding from the National Institutes of Health (K23NS102521). There was no specific funding for this project.

PY - 2018/11/1

Y1 - 2018/11/1

KW - adolescent

KW - calcitonin gene-related peptide

KW - migraine

KW - monoclonal antibody

KW - pediatric

UR - http://www.scopus.com/inward/record.url?scp=85055082428&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85055082428&partnerID=8YFLogxK

U2 - 10.1111/head.13414

DO - 10.1111/head.13414

M3 - Article

C2 - 30324723

AN - SCOPUS:85055082428

SN - 0017-8748

VL - 58

SP - 1658

EP - 1669

JO - Headache

JF - Headache

IS - 10

ER -

Recommendations on the Use of Anti-CGRP Monoclonal Antibodies in Children and Adolescents

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this